Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer.

Alvin Powers, M.D., professor of Medicine and Molecular Physiology and Biophysics, has been named to the American Diabetes Association Board of Directors.

Russ Altman, M.D., Ph.D., professor and chair of Bioengineering at Stanford University, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 6.

It might be possible to generate a “metabolically healthy” state of obesity by targeting signaling pathways that improve insulin sensitivity.

A new computational model of the interactions between vocal folds and the air around them could aid in designing new treatments for voice disorders.